Author:
Guojun Tan,Yan Xu,Weizhi Wang,Lihua Wang,Chunyang Li,Xinghu Zhang,Hongyu Zhou,Huiqing Dong,Meini Zhang,Tao Jin,Huan Yang,Liying Cui,Li Guo
Subject
Neurology (clinical),Neurology,General Medicine
Reference32 articles.
1. The cost burden of multiple sclerosis in the United States: a systematic review of the literature;Adelman;J. Med. Econ.,2013
2. Pathology of demyelinating diseases;BFGh;Annual Rev. Pathol.: Mechanisms of Dis.,2012
3. Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients;Bourdette;Neurol.: Clinical Practice,2016
4. Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta;Castrop;Neuropsychiatr. Dis. Treat.,2013
5. Cost-utility analysis of multiple sclerosis treatment in Thailand;Chanatittarat;Int. J. Technol. Assess Health Care,2018
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献